NEW DELHI, (Reuters) -The drug company Viatris announced on December 23 that the U.S. Food and Drug Administration (FDA) has restricted imports of 11 products made at its facility in Indore ...

With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving ...

and a number of drugs that target these receptors are in clinical use. ∼25,000 scientific papers relate to ERBB-receptor signalling, in which hundreds of receptor interactions are described ...

Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices.

Now that the Assad regime in Syria has fallen, the full scale of that government's production and distribution of illicit drugs is coming ... room where they actually made the pills.

Viatris said on Monday the US Food and Drug Administration has restricted imports of 11 products made at the drugmaker's facility in India after the regulator's inspection found it had violated ...

Viatris said on Monday the US Food and Drug Administration has restricted imports of 11 products made at the drugmaker's facility in India after the regulator's inspection found it had violated ...

The site makes oral finished doses like tablets and capsules. Viatris is working on corrective actions. Viatris said on Monday the U.S. Food and Drug Administration has restricted imports of 11 ...

(Reuters) -Viatris said on Monday the U.S. Food and Drug Administration has restricted imports of 11 products made at the drugmaker’s facility in India after the regulator’s inspection found it had ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Targeted ...

The FDA has issued a warning letter to Viatris related to its drug manufacturing facility in Indore in Madhya Pradesh, the company said, without disclosing the specifics of the warning.

even in cases where the interactions were weak. While quantum computers and AI have made it easier to design small molecules for drug therapies, this has led to a need to develop much faster ...